UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045534
Receipt number R000051975
Scientific Title A Study of the Usefulness of Minimally Invasive Surgery Using Sentinel Lymph Node as an Index in Early Stage Uterine Cancer
Date of disclosure of the study information 2021/09/21
Last modified on 2021/09/21 20:26:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study of the Usefulness of Minimally Invasive Surgery Using Sentinel Lymph Node as an Index in Early Stage Uterine Cancer

Acronym

Sentinel Node Navigation Surgery in Early Stage Uterine Cancer

Scientific Title

A Study of the Usefulness of Minimally Invasive Surgery Using Sentinel Lymph Node as an Index in Early Stage Uterine Cancer

Scientific Title:Acronym

Sentinel Node Navigation Surgery in Early Stage Uterine Cancer

Region

Japan


Condition

Condition

Uterine cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to validate the usefulness and safety of minimally invasive surgery for early-stage uterine cancer by identifying the extent of retroperitoneal lymph node dissection using indocyanine green and infrared camera, using tissue blood flow and sentinel lymph nodes as indicators.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sentinel lymph node identification rate, sensitivity, specificity, negative predictive value, and accuracy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Sentinel Node Navigation Surgery

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Female

Key inclusion criteria

A. Cervical cancer
1. Clinical stage IA1
2. Clinical stage IA2
3. Clinical stage IB1 with a tumor size of 2 cm or less.
4. Clinical stage IIA1 with a tumor size of 2cm or less.
5. Histological diagnosis: squamous cell carcinoma or adenocarcinoma, adenosquamous cell carcinoma
B. Endometrial cancer
1. Clinically advanced stage IA
2. Histological diagnosis: endometrioid carcinoma G1 or G2

Key exclusion criteria

1. Patients who seem to have insufficient judgment
2. Patients with significant lymph node swelling on imaging examination
3. Patients with a history of iodine hypersensitivity
4. Patients with a history of hypersensitivity to ICG components
5. Patients with severe obesity

Target sample size

50


Research contact person

Name of lead principal investigator

1st name kazu
Middle name
Last name ueda

Organization

International University of Health and Welfare, Mita Hospital

Division name

Department of Gynecologic Oncology

Zip code

108-8329

Address

1-4-3 Mita, Minato-ku, Tokyo

TEL

03-3451-8121

Email

kazu@iuhw.ac.jp


Public contact

Name of contact person

1st name kazu
Middle name
Last name ueda

Organization

International University of Health and Welfare, Mita Hospital

Division name

Department of Gynecologic Oncology

Zip code

108-8329

Address

1-4-3 Mita, Minato-ku, Tokyo

TEL

03-3451-8121

Homepage URL


Email

kazu@iuhw.ac.jp


Sponsor or person

Institute

International University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

International University of Health and Welfare

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

International University of Health and Welfare, Mita Hospital

Address

1-4-3 Mita, Minato-ku, Tokyo

Tel

03-3451-8121

Email

kazu@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 04 Month 23 Day

Date of IRB

2021 Year 05 Month 19 Day

Anticipated trial start date

2021 Year 08 Month 31 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 09 Month 21 Day

Last modified on

2021 Year 09 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051975


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name